文献速递儿童神经与发育行为儿童消化与营养

苯妥英或卡马西平单药治疗儿童高同型半胱氨酸血症的横断面研究

Hyperhomocysteinaemia in children receiving phenytoin and carbamazepine monotherapy: a cross-sectional observational study.
PubMed 文献 · Arch Dis Child · 2016-11-07

该横断面观察研究纳入112例接受苯妥英或卡马西平单药治疗超过6个月的2-12岁癫痫患儿,发现90%的患儿存在高同型半胱氨酸血症,显著高于健康对照的34%;血浆同型半胱氨酸与用药时长相关,补充叶酸1个月可降低同型半胱氨酸浓度。

要点

  • 苯妥英或卡马西平单药治疗超过6个月的儿童中90%出现高同型半胱氨酸血症。
  • 用药时间越长,同型半胱氨酸越高、叶酸越低。
  • 补充叶酸1个月可降低血浆同型半胱氨酸浓度。

核心结论

  • 苯妥英或卡马西平单药治疗超过6个月与北印度儿童90%的高同型半胱氨酸血症相关。
  • 补充叶酸可使这些儿童升高的同型半胱氨酸浓度降低。

研究设计与样本

  • 横断面观察研究纳入连续2-12岁癫痫患儿,接受苯妥英或卡马西平单药治疗超过6个月。
  • 测量血浆总同型半胱氨酸、叶酸、维生素B12及抗癫痫药物浓度,并招募年龄性别匹配的健康对照。
  • 同型半胱氨酸>10.4 µmol/L的患儿接受叶酸补充1个月后复测同型半胱氨酸和叶酸。

主要发现

  • 112例单药治疗超过6个月的患儿中,苯妥英组54例(90%)和卡马西平组45例(90%)存在高同型半胱氨酸血症,对照组17例(34%)存在(p<0.05)。
  • 研究组平均血浆同型半胱氨酸显著高于对照组(18.9±10.2 vs 9.1±3 µmol/L)。
  • 研究组血清叶酸(10.04±8.5 vs 12.6±4.8 ng/ml,p<0.001)和维生素B12(365±155 vs 474±332 pg/mL,p=0.02)显著低于对照组。
  • 抗癫痫药物疗程与同型半胱氨酸升高及叶酸降低显著相关(p<0.05)。
  • 补充叶酸1个月后研究组血浆同型半胱氨酸从20.9±10.3 µmol/L降至14.2±8.2 µmol/L(p<0.05)。

关键数值与推荐

  • 高同型半胱氨酸血症定义为血浆同型半胱氨酸>10.4 µmol/L。
  • 苯妥英组高同型半胱氨酸血症54例(90%),卡马西平组45例(90%),对照组17例(34%),p<0.05。
  • 研究组与对照组平均同型半胱氨酸18.9±10.2 vs 9.1±3 µmol/L。
  • 研究组与对照组叶酸10.04±8.5 vs 12.6±4.8 ng/ml(p<0.001),维生素B12 365±155 vs 474±332 pg/mL(p=0.02)。
  • 叶酸补充1个月后同型半胱氨酸从20.9±10.3降至14.2±8.2 µmol/L(p<0.05)。

临床怎么用

  • 对长期使用苯妥英或卡马西平单药的癫痫患儿,应考虑监测血浆同型半胱氨酸、叶酸和维生素B12水平。
  • 对于同型半胱氨酸>10.4 µmol/L的患儿,可考虑补充叶酸1个月后复查同型半胱氨酸。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Long-term therapy with phenytoin and carbamazepine is known to cause hyperhomocysteinaemia. We evaluated the prevalence of hyperhomocysteinaemia in North Indian children receiving phenytoin or carbamazepine monotherapy for >6 months duration and the effect of folic acid supplementation on plasma homocysteine. METHODS: In this cross-sectional observational study we enrolled consecutive children aged 2-12 years with epilepsy who had received phenytoin or carbamazepine monotherapy for >6 months. Plasma total homocysteine, folic acid, vitamin B12 and antiepileptic drug concentrations were measured. Healthy age- and sex-matched controls were recruited. Children with homocysteine >10.4 µmol/L received folic acid supplementation for 1 month and homocysteine and folic acid concentrations were measured after 1 month follow-up. RESULTS: A total of 112 children receiving antiepileptic monotherapy for >6 months were enrolled. Hyperhomocysteinaemia was present in 54 children (90%) receiving phenytoin, 45 children (90%) receiving carbamazepine therapy and 17 (34%) controls (p<0.05). Mean plasma homocysteine concentrations were significantly higher (18.9±10.2 vs 9.1±3 µmol/L) and serum folic acid concentrations (10.04±8.5 ng/ml vs 12.6±4.8 p<0.001) and vitamin B12 concentrations (365±155 pg/mL vs 474±332 pg/mL, p=0.02) were significantly lower in the study group compared with the control group. Duration of antiepileptic drug therapy correlated significantly with elevated homocysteine and reduced folic acid concentrations (p<0.05). Supplementation with folic acid for 1 month led to a reduction in plasma homocysteine concentrations in the study group (from 20.9±10.3 µmol/L to 14.2±8.2 µmol/L, p<0.05). CONCLUSIONS: Phenytoin or carbamazepine monotherapy for >6 months duration is associated with hyperhomocysteinaemia in 90% of North Indian children. Elevated homocysteine concentrations were normalised in these children with folic acid supplementation.

来源:Arch Dis Child,查看原文。版权归原作者所有。

引用

  1. Chandrasekaran S, Patil S, Suthar R, et al. Hyperhomocysteinaemia in children receiving phenytoin and carbamazepine monotherapy: a cross-sectional observational study. Arch Dis Child. 2016. PMID: 27821519. doi:10.1136/archdischild-2016-311436

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。